Mosunetuzumab (Lunsumio)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Mosunetuzumab (Lunsumio), covering 2025-11-03 to 2025-11-03. Get the full timeline:
Most recent: Clinical Trial Update: Mosunetuzumab in Patients With Newly Diagnosed Extranodal Marginal Zone Lymphoma [Phase 2]